Ado-trastuzumab emtansine and Pasireotide Subcutaneous
Determining the interaction of Ado-trastuzumab emtansine and Pasireotide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-Trastuzumab Emtansine
Generic Name: pasireotide
Brand name: Signifor, Signifor LAR
Synonyms: Pasireotide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine-Patanase
- Ado-trastuzumab emtansine-Patiromer
- Ado-trastuzumab emtansine-Patiromer Sorbitex Calcium
- Ado-trastuzumab emtansine-Pavacot
- Ado-trastuzumab emtansine-Paxil
- Ado-trastuzumab emtansine-Paxil (Paroxetine Suspension)
- Pasireotide Subcutaneous-Ado-trastuzumab emtansine Intravenous
- Pasireotide Subcutaneous-Adox Pak 2/100
- Pasireotide Subcutaneous-Adoxa
- Pasireotide Subcutaneous-Adoxa CK
- Pasireotide Subcutaneous-Adoxa Pak
- Pasireotide Subcutaneous-Adoxa Pak 1/100